We found that low AGAP2-AS1 levels were associated with advanced FIGO stage, high histological grade, lymph node metastasis and serous subtype (Table 1), indicating that AGAP2-AS1 negatively correlates with a high degree of malignancy of EOC. Here, AGAP2 is linked to metastatic malignant neoplasm in the lymph nodes.